Skip to content

CORMEDIX INC.: 10-Q filed 2021-11-09

What CORMEDIX INC. reported in its quarterly report filed 2021-11-09 (fiscal Q3 2021): 43 published measures, 112 facts as tagged in accession 0001213900-21-057751.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-09
Fiscal period
fiscal Q3 2021
Accession
0001213900-21-057751 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3075,389,223USD
At 2020-12-3149,308,303USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-306,045,042USD
At 2020-12-315,085,291USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3069,344,181USD
At 2020-12-3144,223,012USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3066,316,229USD
At 2020-12-3141,905,469USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-8,569,366USD92
2021-01-01 to 2021-09-30-20,419,239USD273
2020-07-01 to 2020-09-30-6,600,747USD92
2020-01-01 to 2020-09-30-15,940,738USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-15,285,863USD273
2020-01-01 to 2020-09-30-16,034,152USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-30796,568USD273
2020-01-01 to 2020-09-3035,553USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-07-01 to 2021-09-3038,088USD92
2021-01-01 to 2021-09-30134,539USD273
2020-07-01 to 2020-09-3093,020USD92
2020-01-01 to 2020-09-30183,517USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-3041,757,551USD273
2020-01-01 to 2020-09-3024,777,651USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-2,005,711USD273
2020-01-01 to 2020-09-309,273,640USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-237,868,094USD
At 2020-12-31-217,448,855USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-01-01 to 2021-09-307.72shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-1,250,186USD273
2020-01-01 to 2020-09-30-5,169,395USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-301,367,045USD
At 2020-12-31111,499USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-303,789,361USD273
2020-01-01 to 2020-09-301,983,644USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-8,564,919USD92
2021-01-01 to 2021-09-30-21,657,664USD273
2020-07-01 to 2020-09-30-6,603,755USD92
2020-01-01 to 2020-09-30-21,136,113USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3072,990,670USD
At 2020-12-3148,182,169USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,381USD92
2021-01-01 to 2021-09-3010,565USD273
2020-07-01 to 2020-09-307,800USD92
2020-01-01 to 2020-09-3027,904USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-305,211,032USD
At 2020-12-314,161,583USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-301,106,922USD
At 2020-12-311,128,104USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-308,577,841USD92
2021-01-01 to 2021-09-3021,691,272USD273
2020-07-01 to 2020-09-306,616,862USD92
2020-01-01 to 2020-09-3021,172,016USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-3048,918USD
At 2020-12-31143,564USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-3012,922USD92
2021-01-01 to 2021-09-3033,608USD273
2020-07-01 to 2020-09-3013,107USD92
2020-01-01 to 2020-09-3035,903USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-07-01 to 2021-09-3025,166USD92
2021-01-01 to 2021-09-30100,931USD273
2020-07-01 to 2020-09-3079,913USD92
2020-01-01 to 2020-09-30147,614USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2021-07-01 to 2021-09-303,836,613USD92
2021-01-01 to 2021-09-3011,793,509USD273
2020-07-01 to 2020-09-303,691,507USD92
2020-01-01 to 2020-09-3010,089,252USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-304,741,228USD92
2021-01-01 to 2021-09-309,897,763USD273
2020-07-01 to 2020-09-302,925,355USD92
2020-01-01 to 2020-09-3011,082,764USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3038,086,437shares
At 2020-12-3133,558,096shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-09-3066,552,961USD
At 2020-12-3142,096,783USD
At 2020-09-3034,547,452USD
At 2019-12-3116,525,187USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-30307,078,505USD
At 2020-12-31261,536,061USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-09-3095,502USD
At 2020-12-31102,006USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30929,206USD
At 2020-12-311,014,635USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30952,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-09-301,367,000USD
At 2020-12-31111,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-303,985,663USD
At 2020-12-312,924,351USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-30774,127USD
At 2020-12-311,412,183USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-8,569,366USD92
2021-01-01 to 2021-09-30-21,669,425USD273
2020-07-01 to 2020-09-30-6,600,747USD92
2020-01-01 to 2020-09-30-21,110,133USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-8,573,045USD92
2021-01-01 to 2021-09-30-20,425,743USD273
2020-07-01 to 2020-09-30-6,606,678USD92
2020-01-01 to 2020-09-30-15,938,336USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-308,600,000USD92
2021-01-01 to 2021-09-3020,400,000USD273
2020-07-01 to 2020-09-306,600,000USD92
2020-01-01 to 2020-09-3015,900,000USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-01-01 to 2021-09-3041,843USD273
2020-01-01 to 2020-09-3047,284USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-4,447USD92
2021-01-01 to 2021-09-30-11,761USD273
2020-07-01 to 2020-09-303,008USD92
2020-01-01 to 2020-09-3025,980USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-3010,565USD273
2020-01-01 to 2020-09-3027,904USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-09-3041,455,630USD273
2020-01-01 to 2020-09-303,045,730USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-99,546USD273
2020-01-01 to 2020-09-30-110,889USD274

Inspect the source

Entity
CORMEDIX INC. / CIK 0001410098
Captured
2026-09-20T08:01:45.168Z
SEC response SHA-256
b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))